Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Market Cap	34.66B
Revenue (ttm)	14.05B
Net Income (ttm)	1.75B
Shares Out	91.67M
EPS (ttm)	19.06
PE Ratio	19.84
Forward PE	19.08
Dividend	4.50 (1.19%)
Ex-Dividend Date	Sep 18, 2025

Volume	161,982
Average Volume	165,725
Open	380.95
Previous Close	377.90
Day's Range	372.05 - 384.80
52-Week Range	307.25 - 640.85
Beta	0.70
RSI	19.14
Earnings Date	Feb 3, 2026

About NSE:INDRAMEDCO

Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric s...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 3,035
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDRAMEDCO

Financial Performance

In 2024, NSE:INDRAMEDCO's revenue was 13.56 billion, an increase of 8.97% compared to the previous year's 12.45 billion. Earnings were 1.61 billion, an increase of 29.87%.